APA Zitierstil

Pan, L.(2019). PD-(L)1 inhibitors vs targeted therapy vs their combination as second-line treatment in patients with advanced hepatocellular carcinoma previously treated with sorafenib. Annals of Oncology, 30, iv105. doi:10.1093/annonc/mdz155.384

MLA Zitierstil

Pan, L. "PD-(L)1 Inhibitors Vs Targeted Therapy Vs Their Combination As Second-line Treatment in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib". Annals of Oncology, 30 ( 2019 ): iv105.

Bitte überprüfen Sie diese Angaben auf Richtigkeit, bevor Sie sie in Ihre Arbeit aufnehmen.